Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study
Author:
Funder
Takeda Pharma Vertrieb GmbH & Co. KG., Berlin, Germany.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
https://link.springer.com/content/pdf/10.1007/s00384-021-03943-5.pdf
Reference31 articles.
1. Baumgart DC (2009) The diagnosis and treatment of Crohn’s disease and ulcerative colitis. Dtsch Arztebl Int 106(8):123–133. https://doi.org/10.3238/arztebl.2009.0123
2. Colombel JF (2013) Measuring disability in IBD: the IBD disability index. Gastroenterol Hepatol (N Y) 9(5):300–302
3. Peyrin-Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, Kostanjsek N, Stucki G, Colombel JF, International Programme to Develop New Indexes for Crohn’s Disease g (2012) Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61(2):241–247. https://doi.org/10.1136/gutjnl-2011-300049
4. Colombel JF (2014) IBD therapy: new targets and unmet needs. Nestle Nutr Inst Workshop Ser 79:153–160. https://doi.org/10.1159/000360720
5. Brandes A, Groth A, Gottschalk F, Wilke T, Ratsch BA, Orzechowski HD, Fuchs A, Deiters B, Bokemeyer B (2019) Real-world biologic treatment and associated cost in patients with inflammatory bowel disease. Z Gastroenterol 57(7):843–851. https://doi.org/10.1055/a-0903-2938
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development and validation of a scale to measure the care needs of Crohn’s disease patients: a mixed-methods study;BMC Nursing;2024-07-10
2. Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment;Heliyon;2024-06
3. Development and validation of a scale to measure the care needs of Crohn's Disease Patients;2024-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3